When deciding whether or not to buy a stock, the author of today’s article cautions that, “if you aren’t careful, being fixated on a high P/S ratio can lead you to miss out on some of the best growth stock opportunities” – especially in the biotech industry. To illustrate this, he proceeds to examine two biotech stocks that, based on their P/S ratios, appear to be significantly overvalued – but which may be good buys nonetheless. For more, – CLICK HERE.
2 Overvalued Biotech Stocks Not To Be Overlooked
- by RobH